{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T08:33:25Z","timestamp":1792485205519,"version":"4.5.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    Quinazoline scaffolds are widely recognized in drug discovery for their diverse pharmacological profiles, and several quinazoline derivatives have been reported as phosphodiesterase 7A (PDE7A) inhibitors with potential anti-inflammatory effects. This study aimed to synthesize novel quinazoline derivatives, evaluate their anti-inflammatory activity and investigate their computationally predicted binding to PDE7A. A series of quinazoline hydrazone (6a\u2013j) and benzylthioquinazolinone (7a\u2013c, 8a,b) derivatives were synthesized and structurally characterized using IR,\n                    <jats:sup>1<\/jats:sup>\n                    H\/\n                    <jats:sup>13<\/jats:sup>\n                    C NMR, mass spectrometry, and elemental analysis. Anti-inflammatory activity was evaluated\n                    <jats:italic>in vivo<\/jats:italic>\n                    using the carrageenan-induced rat paw edema model. An acute oral toxicity assessment identified the highest tested doses without observed mortality or overt clinical toxicity of 1000\u20131200\u00a0mg\/kg, from which anti-inflammatory test doses of 100\u2013120\u00a0mg\/kg were selected. Compound 6f produced the highest numerical inhibition among the synthesized derivatives, with 79.39% inhibition at 100\u00a0mg\/kg. Compounds 6a, 6b, and 8a produced 61.85%, 61.65%, and 60.12% inhibition, respectively, at 120\u00a0mg\/kg, whereas diclofenac produced 68.21% inhibition at 7.5\u00a0mg\/kg. Molecular docking, Prime MM\u2013GBSA calculations, and 100-ns molecular dynamics simulations were used to evaluate predicted PDE7A interactions and comparative dynamic behavior. Compound 6f showed the most favorable Glide GScore and IFDScore, persistent Tyr211 and Gln413 hydrogen bonds, and the clearest apparent late-stage stationary root-mean-square deviation regime. In silico ADMET analysis indicated acceptable predicted drug-likeness and absorption-related properties, although moderate-to-low aqueous solubility and predicted hERG liability require experimental evaluation. Overall, compound 6f was prioritized as the leading anti-inflammatory candidate within the evaluated series; however, PDE7A involvement remains computationally inferred and requires direct biochemical and selectivity validation.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2026.1859798","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:22:58Z","timestamp":1787286178000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["New quinazoline derivatives with anti-inflammatory activity and computationally predicted PDE7A binding: synthesis, molecular modeling, and in silico pharmacokinetic evaluation"],"prefix":"10.3389","volume":"17","author":[{"given":"Majed","family":"Alharbi","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, King Abdulaziz University","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwaq A.","family":"Almagati","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, King Abdulaziz University","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdy M.","family":"Gineinah","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, King Abdulaziz University","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afaf A.","family":"El-Malah","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, King Abdulaziz University","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed B.","family":"Hawsawi","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Faculty of Science, Umm Al-Qura University","place":["Makkah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Jaffar Sadiq","family":"Mantargi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Pharmacy Program, Batterjee Medical College","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anfal S.","family":"Aljahdali","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, King Abdulaziz University","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.bmcl.2015.02.025","article-title":"Synthesis, anticonvulsant activity and molecular modeling study of some new hydrazinecarbothioamide, benzenesulfonohydrazide, and phenacylacetohydrazide analogues of 4 (3H)-quinazolinone","volume":"25","author":"Al-Salem","year":"2015","journal-title":"Bioorg. and Med. Chem. Lett."},{"key":"B2","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ejmech.2016.05.066","article-title":"Synthesis, anti-inflammatory, analgesic, COX-1\/2 inhibitory activities and molecular docking studies of substituted 2-mercapto-4 (3H)-quinazolinones","volume":"121","author":"Alaa","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"B3","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/prot.22102","article-title":"Very fast prediction and rationalization of pKa values for protein\u2013ligand complexes","volume":"73","author":"Bas","year":"2008","journal-title":"Proteins Struct. Funct. Bioinforma."},{"key":"B4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/jhet.4768","article-title":"4\u2010substituted push\u2010pull quinazoline chromophores with extended \u03c0conjugated linker","volume":"61","author":"Bonnaud","year":"2024","journal-title":"J. Heterocycl. Chem."},{"key":"B5","unstructured":"What is an LD50 and LC50?\n          \n          \n          2018"},{"key":"B6","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/cmdc.200900043","article-title":"Synthesis, structural analysis, and biological evaluation of thioxoquinazoline derivatives as phosphodiesterase 7 inhibitors","volume":"4","author":"Casta\u00f1o","year":"2009","journal-title":"ChemMedChem Chem. Enabling Drug Discov."},{"key":"B7","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1039\/JR9470000775","article-title":"151. Synthetic antimalarials. Part XIV. Some 2-arylamino-4-aminoalkylaminoquinazolines","volume":"150","author":"Curd","year":"1947","journal-title":"J. Chem. Soc."},{"key":"B8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jscs.2011.04.001","article-title":"Synthesis and antimicrobial activity of novel quinazolinone\u2013thiazolidine\u2013quinoline compounds","volume":"17","author":"Desai","year":"2013","journal-title":"J. Saudi Chem. Soc."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1389076","DOI":"10.3389\/fphar.2024.1389076","article-title":"Design, synthesis, molecular docking, and molecular dynamic studies of novel quinazoline derivatives as phosphodiesterase 7 inhibitors","volume":"15","author":"El-Malah","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.21608\/ejchem.2019.7130.1587","article-title":"Ultrasound one pot synthesis of fused quinazolinones and quinazolinediones, screening and molecular docking study as phosphodiesterase 7A inhibitors","volume":"62","author":"Elfeky","year":"2019","journal-title":"Egypt. J. Chem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/jhet.5570270304","article-title":"A convenient synthesis of 3\u2010aryl\u20101, 2, 4\u2010triazolo [4, 3\u2010c] quinazolines","volume":"27","author":"ElKerdawy","year":"1990","journal-title":"J. Heterocyclic Chemistry"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1016\/j.bmc.2005.12.032","article-title":"New insights about HERG blockade obtained from protein modeling, potential energy mapping, and docking studies","volume":"14","author":"Farid","year":"2006","journal-title":"Bioorg. and Medicinal Chemistry"},{"key":"B13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/ilar.43.4.191","article-title":"The design and statistical analysis of animal experiments","volume":"43","author":"Festing","year":"2002","journal-title":"ILAR Journal"},{"key":"B14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/0023677218783223","article-title":"Guidelines on statistics for researchers using laboratory animals: the essentials","volume":"53","author":"Gosselin","year":"2019","journal-title":"Lab. Animals"},{"key":"B15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1021\/ci100275a","article-title":"Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations","volume":"51","author":"Hou","year":"2011","journal-title":"J. Chemical Information Modeling"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1021\/acs.jctc.3c00044","article-title":"Epik: p K a and protonation state prediction through machine learning","volume":"19","author":"Johnston","year":"2023","journal-title":"J. Chemical Theory Computation"},{"key":"B17","doi-asserted-by":"publisher","first-page":"4521","DOI":"10.1021\/acs.jcim.1c00794","article-title":"Systematic comparison of the structural and dynamic properties of commonly used water models for molecular dynamics simulations","volume":"61","author":"Kadaoluwa Pathirannahalage","year":"2021","journal-title":"J. Chemical Information Modeling"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1021\/jm9506938","article-title":"Synthesis and hypolipidemic activities of novel 2-[4-[(diethoxyphosphoryl) methyl] phenyl] quinazolines and 4 (3 H)-quinazolinones","volume":"39","author":"Kurogi","year":"1996","journal-title":"J. Medicinal Chemistry"},{"key":"B19","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: improving force field accuracy on challenging regimes of chemical space","volume":"17","author":"Lu","year":"2021","journal-title":"J. Chemical Theory Computation"},{"key":"B20","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Madhavi Sastry","year":"2013","journal-title":"J. Computer-Aided Molecular Design"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.3390\/molecules28041761","article-title":"Structure-based virtual screening and molecular dynamics simulation assessments of depsidones as possible selective cannabinoid receptor type 2 agonists","volume":"28","author":"Mohamed","year":"2023","journal-title":"Molecules"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1016\/j.bmc.2007.11.049","article-title":"Novel quinazolinone derivatives as 5-HT7 receptor ligands","volume":"16","author":"Na","year":"2008","journal-title":"Bioorg. and Medicinal Chemistry"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e15937","DOI":"10.1371\/journal.pone.0015937","article-title":"PDE 7 inhibitors: new potential drugs for the therapy of spinal cord injury","volume":"6","author":"Paterniti","year":"2011","journal-title":"PloS One"},{"key":"B24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ejmech.2011.10.040","article-title":"Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke model","volume":"47","author":"Redondo","year":"2012","journal-title":"Eur. Journal Medicinal"},{"key":"B25","first-page":"826","article-title":"On various derivatives of 2-(o. ethoxyphenyl)-1, 3, 4-oxadiazole 5-mercapto-subtituted","volume":"106","author":"Russo","year":"1967","journal-title":"Boll. Chimico Farmaceutico"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1016\/j.bmc.2013.01.067","article-title":"Synthesis and evaluation of quinazoline derivatives as phosphodiesterase 7 inhibitors","volume":"21","author":"S\u00e1nchez","year":"2013","journal-title":"Bioorg. and Medicinal Chemistry"},{"key":"B27","year":"2024"},{"key":"B28","volume-title":"Maestro-Desmond Interoperability Tools","year":"2024"},{"key":"B29","volume-title":"Schr\u00f6dinger Release 2024-3: Glide","year":"2024"},{"key":"B30","volume-title":"Schr\u00f6dinger Release 2024-3: Prime","year":"2024"},{"key":"B31","volume-title":"Schr\u00f6dinger Release 2024-3: QikProp","year":"2024"},{"key":"B32","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.sajb.2020.08.013","article-title":"Phosphodiesterase 1 inhibition and molecular docking study of phytochemicals isolated from stem heartwood of heterophragma adenophyllum seem","volume":"135","author":"Shah","year":"2020","journal-title":"South Afr. J. Bot."},{"key":"B33","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1021\/jm050540c","article-title":"Novel procedure for modeling ligand\/receptor induced fit effects","volume":"49","author":"Sherman","year":"2006","journal-title":"J. Medicinal Chemistry"},{"key":"B34","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3390\/pharmaceutics13050597","article-title":"PK\/PD modeling of the PDE7 inhibitor\u2014GRMS-55 in a mouse model of autoimmune hepatitis","volume":"13","author":"\u015awierczek","year":"2021","journal-title":"Pharmaceutics"},{"key":"B35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ejmech.2015.04.009","article-title":"Design and synthesis of 3-(3-((9H-carbazol-4-yl) oxy)-2-hydroxypropyl)-2-phenylquinazolin-4 (3H)-one derivatives to induce ACE inhibitory activity","volume":"96","author":"Venkatesh","year":"2015","journal-title":"Eur. Journal Medicinal Chemistry"},{"key":"B36","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1289\/ehp.98106497","article-title":"Acute oral toxicity","volume":"106","author":"Walum","year":"1998","journal-title":"Environ. Health Perspectives"},{"key":"B37","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.yrtph.2014.12.019","article-title":"Relationship between lethal toxicity in oral administration and injection to mice: effect of exposure routes","volume":"71","author":"Wang","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ejmech.2015.03.053","article-title":"Distinct novel quinazolinone exhibits selective inhibition in MGC-803 cancer cells by dictating mutant p53 function","volume":"95","author":"Zhang","year":"2015","journal-title":"Eur. Journal Medicinal Chemistry"},{"key":"B39","doi-asserted-by":"publisher","first-page":"155156","DOI":"10.1016\/j.tetlet.2024.155156","article-title":"Synthesis of quinazolinone derivatives with a seven\u2010membered ring using borrowing hydrogen methodology","volume":"145","author":"Zhou","year":"2024","journal-title":"Tetrahedron Lett."},{"key":"B40","doi-asserted-by":"publisher","first-page":"3864","DOI":"10.1016\/j.ejmech.2010.05.040","article-title":"Synthesis and evaluation of 4-quinazolinone compounds as potential antimalarial agents","volume":"45","author":"Zhu","year":"2010","journal-title":"Eur. J. Med. Chem."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1859798\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:23:00Z","timestamp":1787286180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1859798\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":40,"alternative-id":["10.3389\/fphar.2026.1859798"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1859798","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"article-number":"1859798"}}